An oxovanadium(IV) complex protects murine bone marrow cells against cisplatin-induced myelotoxicity and DNA damage
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An oxovanadium(IV) complex protects murine bone marrow cells against cisplatin-induced myelotoxicity and DNA damage
Authors
Keywords
-
Journal
DRUG AND CHEMICAL TOXICOLOGY
Volume 40, Issue 3, Pages 359-367
Publisher
Informa UK Limited
Online
2016-11-21
DOI
10.1080/01480545.2016.1237522
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Perspectives for vanadium in health issues
- (2016) Dieter Rehder Future Medicinal Chemistry
- Prevention of cyclophosphamide-induced hepatotoxicity and genotoxicity: Effect of an l-cysteine based oxovanadium(IV) complex on oxidative stress and DNA damage
- (2015) Abhishek Basu et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Squalene Selectively Protects Mouse Bone Marrow Progenitors Against Cisplatin and Carboplatin-Induced Cytotoxicity In Vivo Without Protecting Tumor Growth
- (2015) Bikul Das et al. NEOPLASIA
- Vanadium as a chemoprotectant: effect of vanadium(III)-l-cysteine complex against cyclophosphamide-induced hepatotoxicity and genotoxicity in Swiss albino mice
- (2014) Abhishek Basu et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Persistence of Cisplatin-Induced Mutagenicity in Hematopoietic Stem Cells: Implications for Secondary Cancer Risk Following Chemotherapy
- (2014) Stephen D. Dertinger et al. TOXICOLOGICAL SCIENCES
- Chemoprotection byd-methionine against cisplatin-induced side-effects: insight from in vitro studies using human plasma
- (2013) Melani Sooriyaarachchi et al. Metallomics
- Induction of DNA fragmentation, chromosome aberrations and micronuclei by cisplatin in rat bone-marrow cells: Protective effect of recombinant human erythropoietin
- (2012) Karima Rjiba-Touati et al. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
- Synthesis, characterization and chemoprotective activity of polyoxovanadates against DNA alkylation
- (2011) Giovana G. Nunes et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
- (2011) Ana-Maria Florea et al. Cancers
- Vanadium in the detection, prevention and treatment of cancer: The in vivo evidence
- (2010) Anupam Bishayee et al. CANCER LETTERS
- Potential Use of Vanadium Compounds in Therapeutics
- (2010) D. A. Barrio et al. CURRENT MEDICINAL CHEMISTRY
- A Review of Current Toxicological Concerns on Vanadium Pentoxide and Other Vanadium Compounds: Gaps in Knowledge and Directions for Future Research
- (2009) Farida Louise Assem et al. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS
- Fifty years of cytogenetics: A parallel view of the evolution of cytogenetics and genotoxicology
- (2008) J.M. Garcia-Sagredo Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Concurrent Weekly Cisplatin Chemotherapy and Radiotherapy in a Haemodialysis Patient with Locally Advanced Cervix Cancer
- (2008) M.A. Zahra et al. CLINICAL ONCOLOGY
- Inhalative Exposure to Vanadium Pentoxide Causes DNA Damage in Workers: Results of a Multiple End Point Study
- (2008) Veronika A. Ehrlich et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Cisplatin: a review of toxicities and therapeutic applications
- (2008) K. Barabas et al. Veterinary and Comparative Oncology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started